5HYQ
Cetuximab Fab in complex with amidated meditope
Experimental procedure
Experimental method | SINGLE WAVELENGTH |
Source type | ROTATING ANODE |
Source details | RIGAKU MICROMAX-007 HF |
Temperature [K] | 100 |
Detector technology | IMAGE PLATE |
Collection date | 2016-01-12 |
Detector | RIGAKU RAXIS IV++ |
Wavelength(s) | 1.5418 |
Spacegroup name | P 21 21 21 |
Unit cell lengths | 64.130, 82.510, 212.230 |
Unit cell angles | 90.00, 90.00, 90.00 |
Refinement procedure
Resolution | 32.529 - 2.477 |
R-factor | 0.1678 |
Rwork | 0.166 |
R-free | 0.20790 |
Structure solution method | MOLECULAR REPLACEMENT |
Starting model (for MR) | 4gw1 |
RMSD bond length | 0.007 |
RMSD bond angle | 0.899 |
Data reduction software | XDS |
Data scaling software | XSCALE |
Phasing software | MOLREP |
Refinement software | PHENIX ((1.10_2155)) |
Data quality characteristics
Overall | Outer shell | |
Low resolution limit [Å] | 32.530 | 2.540 |
High resolution limit [Å] | 2.477 | 2.480 |
Rmerge | 0.064 | 0.270 |
Number of reflections | 40620 | |
<I/σ(I)> | 22.9 | |
Completeness [%] | 99.1 | 88.9 |
Redundancy | 5.1 | 3.5 |
Crystallization Conditions
crystal ID | method | pH | temperature | details |
1 | VAPOR DIFFUSION, HANGING DROP | 293 | 0.1 M citrate, 0.1 M sodium hydrogen phosphate, 0.5 M potassium hydrogen phosphate, 1.6 M sodium dihydrogen phosphate |